CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP · Real-Time Price · USD
47.49
+0.79 (1.69%)
At close: Jun 27, 2025, 4:00 PM
47.00
-0.49 (-1.03%)
After-hours: Jun 27, 2025, 7:56 PM EDT
CRISPR Therapeutics AG Market Cap
CRISPR Therapeutics AG has a market cap or net worth of $4.36 billion as of June 27, 2025. Its market cap has decreased by -14.47% in one year.
Market Cap
4.36B
Enterprise Value
2.72B
1-Year Change
-14.47%
Ranking
Category
Stock Price
$47.49
Market Cap Chart
Since October 19, 2016, CRISPR Therapeutics AG's market cap has increased from $560.10M to $4.36B, an increase of 677.92%. That is a compound annual growth rate of 26.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 4.03B | 20.05% |
| Dec 31, 2024 | 3.36B | -32.44% |
| Dec 29, 2023 | 4.97B | 56.24% |
| Dec 30, 2022 | 3.18B | -45.12% |
| Dec 31, 2021 | 5.80B | -46.39% |
| Dec 31, 2020 | 10.82B | 221.74% |
| Dec 31, 2019 | 3.36B | 126.76% |
| Dec 31, 2018 | 1.48B | 53.95% |
| Dec 29, 2017 | 963.10M | 19.42% |
| Dec 30, 2016 | 806.50M | 43.99% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 700.24B |
| Johnson & Johnson | 366.76B |
| AbbVie | 327.47B |
| Novo Nordisk | 299.93B |
| UnitedHealth Group | 278.98B |
| Novartis AG | 235.02B |
| Abbott Laboratories | 233.24B |
| AstraZeneca | 215.99B |